Oncology
Patient-Reported Outcomes From AMPLITUDE, a Randomized, Placebo-Controlled Phase 3 Trial of Niraparib and Abiraterone Acetate Plus Prednisone in Metastatic Hormone-Sensitive Prostate Cancer With Homologous Recombination Repair Mutations
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.